Despite the lack of clarity on the impact of overactive GST proteins on the overall survival of cancer patients, there is a popular consensus that higher expression of GST proteins drives tumor pathogenicity and results in poor outcomes [12,13,59,214]. Here, GSTK1 is linked to neoplasm.